Cargando…
The impact of body weight on rivaroxaban pharmacokinetics
ESSENTIALS: The optimal dosing strategy of rivaroxaban for patients at the extremes of body weight is not known. A pharmacokinetic study was conducted based in real‐world patients in a London teaching hospital. In the cohort of patients studied, weight on its own did not impact significantly on riva...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058267/ https://www.ncbi.nlm.nih.gov/pubmed/30046688 http://dx.doi.org/10.1002/rth2.12039 |